Lanean...
Extinguishing The Embers: Targeting AML Metabolism
Acute myeloid leukemia (AML) is a cancer derived from the myeloid lineage of blood cells, characterized by overproduction of leukemic blasts. Although therapeutic improvements have made a significant impact on AML patient outcomes, survival rates remain low due to high incidence of relapse. Similar...
Gorde:
| Argitaratua izan da: | Trends Mol Med |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8005405/ https://ncbi.nlm.nih.gov/pubmed/33121874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmed.2020.10.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|